Cyrus Biotechnology

About:

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

Top Investors: Alumni Ventures, OrbiMed, Alexandria Venture Investments, Agent Capital, Trinity Ventures

Description:

Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools. It was founded in 2014 and headquartered in Seattle, Washington.

Total Funding Amount:

$46.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)cyrusbio.com

Founders:

Javier Castellanos, Lucas Nivon, Yifan Song

Number of Employees:

11-50

Last Funding Date:

2024-02-26

IPO Status:

Private

Industries: